GlassScriptPhysician profile
James Paul Taylor
NPI 1396130209
$19,163.50
in general payments reported to CMS, 2019-2025
9 companies · $6,563 in 2025
The $6,563 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,412 · 2023: $4,841 · 2024: $3,348 · 2025: $6,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $1,731 · Consulting Fee: $1,500 · Travel and Lodging: $1,448 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,056.58 |
| Food and Beverage | $1,731.02 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,448.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,305.92 | 2022-2025 | Da Vinci Surgical System |
| Virtual Incision Corporation | $3,206.00 | 2024 | Mira |
| Ethicon US, LLC | $197.17 | 2023 | Echelon; Endopath, Echelon Circular |
| Medtronic, INC. | $166.87 | 2025 | Signia |
| Conmed Corporation | $141.95 | 2024 | |
| Coloplast Corp | $93.22 | 2023 | |
| Deciphera Pharmaceuticals INC. | $21.69 | 2025 | Qinlock, Romvimza |
| Merck Sharp & Dohme LLC | $17.62 | 2025 | Keytruda |
| Guard Medical INC. | $13.06 | 2023 | Npseal (5), Npseal Large, Npseal Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.